Vyant Bio Inc reports results for the quarter ended in June - Earnings Summary

Vyant Bio

22/08/2022 22:01

* Vyant Bio Inc  VYNT.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 15 cents per
share.
    * Revenue was $165.00 thousand​; analysts expected $200.00
thousand. 
    * Vyant Bio Inc's reported EPS for the quarter was a loss
of 20
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vyant Bio Inc shares had fallen by 17.0% this quarter and
lost 44.1% so far this year.
    * The company reported a quarterly loss of $5.81 million.
    * Wall Street's median 12-month price target for Vyant Bio
Inc is
$3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 22
at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.15          -0.20          Missed
 Mar. 31 2022      -0.16          -0.32          Missed
 Dec. 31 2021      -0.16          -0.04          Beat
 Sep. 30 2021      -0.15          -0.15          Met